Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
US Blood Glucose Monitoring Systems Market Report
... report include: Traditional Glucose Monitoring Continuous Glucose Monitoring (CGM) Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. Highlights ... Read More
-
Type 2 Diabetes (T2D) - Pipeline Analysis
... in various phases (Discovery, Preclinical, Clinical & Marketing). The pipeline focuses on novel pharmacologic drugs & regenerative medicines covering small molecules, monoclonal antibodies, stem cell therapies, Gene therapies, Recombinant proteins and RNA-based therapeutics, but excludes ... Read More
-
Sectoral Capsule-Anti Diabetic Drugs Market in India (2009 - 2018)
... a CAGR of 11.30 percent from 2013 to2018. Rise in obese and geriatric population, innovation of new drugs, rapid market adoption ofdrugs and rising income are driving the growth of the market. Due to changes ... Read More
Research Assistance
